Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page
- Check3 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check10 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.4.2 was added; prior updates and notices, including Revision: v3.4.1 and a government funding/operating status notice, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check39 days agoChange DetectedAdded a general site notice about potential delays due to government funding and updated the revision tag to v3.4.1, removing the previous v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check46 days agoChange DetectedThe page now shows a glossary toggle and new QC metadata (Last Update Submitted that Met QC Criteria) and a new revision (Revision: v3.4.0), while older QC metadata (Last Update Submitted that met QC Criteria), No FEAR Act data, and the previous revision (v3.3.4) were removed.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page revision was updated from v3.3.3 to v3.3.4 without changes to study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.